Prevention of the recurrence of anaemia in Gambian children following discharge from hospital

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Bojang, Kalifa A ^a   Milligan, Paul J M ^b   Conway, David J ^a   Sisay Joof, Fatou ^a   Jallow, Muminatou ^a   Nwakanma, Davis C ^a   Abubakr, Ismaela ^a   Njie, Fanta ^a   Greenwood, Brian ^b  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; FANSIDAR; FERROUS FUMARATE; HEMOGLOBIN; IRON; PLACEBO; ANTIMALARIAL AGENT; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

ANEMIA; ARTICLE; CHEMOPROPHYLAXIS; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GAMBIA; HEALTH CARE ACCESS; HEALTH CENTER; HEMOGLOBIN BLOOD LEVEL; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; IRON THERAPY; MAJOR CLINICAL STUDY; MALARIA; MALE; MORBIDITY; MORTALITY; NUTRITIONAL STATUS; OUTPATIENT; PARASITEMIA; PATIENT COMPLIANCE; PATIENT MONITORING; PRESCHOOL CHILD; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SKIN MANIFESTATION; SPLENOMEGALY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; ANIMAL; CONTROLLED CLINICAL TRIAL; DISEASE TRANSMISSION; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; DRUG TOXICITY; GENETIC MARKER; GENETICS; GENOTYPE; HOSPITAL; PARASITE; PHYSIOLOGY;

ANEMIA; ANIMALS; ANTIMALARIALS; DRUG COMBINATIONS; DRUG RESISTANCE; DRUG TOXICITY; FEMALE; GAMBIA; GENETIC MARKERS; GENOTYPE; HOSPITALS; HUMANS; MALARIA; MALE; NUTRITIONAL STATUS; PARASITES; PATIENT COMPLIANCE; PATIENT DISCHARGE; PYRIMETHAMINE; RECURRENCE; SULFADOXINE;

EID: 77955291809     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011227     Document Type: Article

References (33)

1. Lackritz EM, Campbell CC, Ruebush TK, 2nd, Hightower AW, Wakube W, et al. (1992) Effect of blood transfusion on survival among children in a Kenyan hospital. Lancet 340: 524-8.
2. Hedberg K, Shaffer N, Davachi F, Hightower A, Lyamba B, et al. (1993) Plasmodium falciparum-associated anemia in children at a large urban hospital in Zaire. Am J Trop Med Hyg 48: 365-71.
3. Slutsker L, Taylor TE, Wirima JJ, Steketee RW (1994) In-hospital morbidity and mortality due to malaria-associated severe anaemia in two areas of Malawi with different patterns of malaria infection. Trans R Soc Trop Med Hyg 88: 548-51.
4. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, et al. (1995) Indicators of life-threatening malaria in African children. N Engl J Med 332: 1399-404.
5. Bojang KA, Palmer A, Boele van Hensbroek M, Banya WA, Greenwood BM (1997) Management of severe malarial anaemia in Gambian children. Trans R Soc Trop Med Hyg 91: 557-61.
6. Schellenberg D, Menendez C, Kahigwa E, Font F, Galindo C, et al. (1999) African children with malaria in an area of intense P. falciparum transmission: features on admission to hospital and risk factors for death. Am J Trop Med Hyg 61: 431-438.
7. Emerton DG (1993) An audit of the management of malaria in a Tanzanian district hospital. Trans R Soc Trop Med Hyg 86: 476-8.
8. Brewster DR, Greenwood BM (1993) Seasonal variation of paediatric diseases in The Gambia, West Africa. Ann Trop Paediatr 13: 133-46.
9. Craighead IB, Knowles JK (1993) Prevention of transfusion-associated HIV transmission with the use of a transfusion protocol for under 5s. Trop Doct 23: 59-61.
10. Biemba G, Dolmans D, Thuma PE, Weiss G, Gordeuk VR (2000) Severe anaemia in Zambian children with Plasmodium falciparum malaria. Trop Med Int Health 5: 9-16.
11. Zucker JR, Lackritz EM, Ruebush TK, 2nd, Hightower AW, Adungosi JE, et al. (1996) Childhood mortality during and after hospitalization in western Kenya: effect of malaria treatment regimens. Am J Trop Med Hyg 55: 655-60.
12. Lackritz EM, Hightower AW, Zucker JR, Ruebush TK, 2nd, Onudi CO, et al. (1997) Longitudinal evaluation of severely anemic children in Kenya: the effect of transfusion on mortality and hematologic recovery. AIDS 11: 1487-94.
13. Dicko A, Sagara I, Sissoko MS, Guindo O, Diallo AI, et al. (2008) Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali. Malar J 7: 123.
14. Cissé B, Sokhna C, Boulanger D, Milet J, Bâ E, et al. (2006) Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebocontrolled, double-blind trial. Lancet 367: 659-67.
15. Sokhna C, Cissé B, Bâel H, Milligan P, Hallett R, et al. (2008) A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children. PLoS ONE 23;3: e1471.
16. Kweku M, Liu D, Adjuik M, et al. (2008) Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial. PLoS ONE 3: e 4000.
17. Hay SI, Rogers DJ, Toomer JF, Snow RW (2000) Annual Plasmodium falciparum entomological inoculation rates (EIR) across Africa: literature survey, Internet access and review. Trans R Soc Trop Med Hyg 94: 113-27.
18. Dunyo S, Ord R, Hallett R, Jawara M, Walraven G, et al. (2006) Randomised Trial of Chloroquine/Sulphadoxine-Pyrimethamine in Gambian Children with Malaria: Impact against Multidrug-Resistant P. falciparum. PLoS Clin Trials 1: e14.
19. Greenwood BM, Armstrong JRM (1991) Comparison of two simple methods for determining malaria parasite density. Tran Roy Soc Trop Med Hyg 85: 186-88.
20. Plowe, Djimde' A, Bouare M, Doumbo O, Wellems TE (1995) Pyrimethamineand proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg 52: 565-8.
21. Duraisingh MT, Curtis J, Warhurst DC (1998) Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Exp Parasitol 89: 1-8.
22. Wacholder S (1986) Binomial regression in GLIM: estimating risk ratios and risk differences. Am J Epidemiol 123: 174-184.
23. Schellenberg D, Menendez C, Kahigwa E, Aponte J, Vidal J, et al. (2001) Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet 3577: 1471-7.
24. Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, et al. (2006) Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lance 367: 133-43.
25. Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, et al. (2008) Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet 372: 1545-54.
26. Brabin BJ, Premji Z, Verhoeff F (2001) An analysis of anemia and child mortality. A synthesis of available data on childhood mortality in relation to malaria and anemia. J Nutr 131: 636S-645S.
27. Ghattas H, Fulford T, Prentice A (2003) Effect of moderate anaemia on later mortality in rural African children. Lancet 361: 2048-50.
28. Zucker JR, Ruebush TK, 2nd, Obonyo C, Otieno J, Campbell CC (2003) The mortality consequences of the continued use of chloroquine in Africa: experience in Siaya, western Kenya. Am J Trop Med Hyg 68: 386-90.
29. Ntab B, Cissé B, Boulanger D, Sokhna C, Targett G, et al. (2007) Impact of intermittent preventive anti-malarial treatment on the growth and nutritional status of preschool children in rural Senegal (West Africa). Am J Trop Med Hyg 77: 411-7.
30. Desai MR, Mei JV, Kariuki SK, Wannemuehler KA, Phillips-Howard PA, et al. (2003) Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine-pyrimethamine for the treatment of mild childhood anemia in western Kenya. J Infect Dis 187: 658-66.
31. Verhoef H, West CE, Nzyuko SM, de Vogel S, van der Valk, et al. (2002) Intermittent administration of iron and sulfadoxine-pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet 360: 908-14.
32. Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, et al. (2009) Efficacy and safety of intermittent preventive treatment with sulfadoxinepyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet 374: 1533-42.
33. Barnes KI, Little F, Smith PJ, Evans A, Watkins WM, White NJ (2006) Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications. Clin Pharmacol Ther 80: 582-96.